Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1994 Feb 1;179(2):569–578. doi: 10.1084/jem.179.2.569

The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure

PMCID: PMC2191352  PMID: 8294868

Abstract

We investigated whether the third component of complement (C3) is involved in the pathophysiology of endotoxic shock, and if it is involved, whether it plays a protective role or whether it mediates shock and multiple organ failure. In a prospective, controlled investigation, six Brittany spaniels that were homozygous for a genetically determined deficiency of C3 (C3 deficient, < 0.003% of normal serum C3 levels) and six heterozygous littermates (controls, approximately 50% of mean normal serum C3 level) were given 2 mg/kg of reconstituted Escherichia coli 026:B6 acetone powder as a source of endotoxin, intravenously. All animals were given similar fluid and prophylactic antibiotic therapy, and had serial hemodynamic variables obtained. After E. coli endotoxin infusion, C3-deficient animals had higher peak levels of endotoxin and less of a rise in temperature than controls (P < 0.05). During the first 4 h after E. coli endotoxin infusion, C3-deficient animals had significantly greater decreases in mean central venous pressure and mean pulmonary artery pressure than controls (P < 0.02). During the first 48 h after E. coli endotoxin infusion, C3-deficient animals had significantly greater decreases in mean arterial pH, left ventricular ejection fraction, and mean pulmonary capillary wedge pressure, and greater increases in mean arterial lactate, arterial-alveolar O2 gradient, and transaminases (aspartate aminotransferase and alanine aminotransferase) than controls, (all P < 0.05). After E. coli endotoxin infusion, C3- deficient animals compared to controls had significantly less of a decrease in mean C5 levels (P < 0.01), but similar (P = NS) increases in circulating tumor necrosis factor levels, bronchoalveolar lavage neutrophils, and protein, and similar (P = NS) decreases in blood leukocytes and platelets. Two of six C3-deficient animals and two of six controls died. In summary, after intravenous infusion of E. coli endotoxin, canines with C3 deficiency have decreased endotoxin clearance and worse E. coli endotoxin-induced shock and organ damage. Thus, the third component of the complement system plays a beneficial role in the host defense against E. coli endotoxic shock.

Full Text

The Full Text of this article is available as a PDF (908.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Björk J., Hugli T. E., Smedegård G. Microvascular effects of anaphylatoxins C3a and C5a. J Immunol. 1985 Feb;134(2):1115–1119. [PubMed] [Google Scholar]
  2. Brandtzaeg P., Mollnes T. E., Kierulf P. Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis. 1989 Jul;160(1):58–65. doi: 10.1093/infdis/160.1.58. [DOI] [PubMed] [Google Scholar]
  3. Cobb J. P., Natanson C., Hoffman W. D., Lodato R. F., Banks S., Koev C. A., Solomon M. A., Elin R. J., Hosseini J. M., Danner R. L. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med. 1992 Oct 1;176(4):1175–1182. doi: 10.1084/jem.176.4.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Craddock P. R., Hammerschmidt D., White J. G., Dalmosso A. P., Jacob H. S. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest. 1977 Jul;60(1):260–264. doi: 10.1172/JCI108763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eichacker P. Q., Hoffman W. D., Farese A., Banks S. M., Kuo G. C., MacVittie T. J., Natanson C. TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J Appl Physiol (1985) 1991 Nov;71(5):1979–1989. doi: 10.1152/jappl.1991.71.5.1979. [DOI] [PubMed] [Google Scholar]
  6. Eichacker P. Q., Hoffman W. D., Farese A., Danner R. L., Suffredini A. F., Waisman Y., Banks S. M., Mouginis T., Wilson L., Rothlein R. Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shock. J Appl Physiol (1985) 1993 Apr;74(4):1885–1892. doi: 10.1152/jappl.1993.74.4.1885. [DOI] [PubMed] [Google Scholar]
  7. Fearon D. T., Ruddy S., Schur P. H., McCabe W. R. Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med. 1975 May 1;292(18):937–940. doi: 10.1056/NEJM197505012921802. [DOI] [PubMed] [Google Scholar]
  8. Fehr J., Jacob H. S. In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions. Studies based on the acute neutropenia of filtration leukophoresis. J Exp Med. 1977 Sep 1;146(3):641–652. doi: 10.1084/jem.146.3.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Flick M. R., Horn J. K., Hoeffel J. M., Goldstein I. M. Reduction of total hemolytic complement activity with Naja haje cobra venom factor does not prevent endotoxin-induced lung injury in sheep. Am Rev Respir Dis. 1986 Jan;133(1):62–67. doi: 10.1164/arrd.1986.133.1.62. [DOI] [PubMed] [Google Scholar]
  10. Garner R., Chater B. V., Brown D. L. The role of complement in endotoxin shock and disseminated intravascular coagulation: experimental observations in the dog. Br J Haematol. 1974 Nov;28(3):393–401. doi: 10.1111/j.1365-2141.1974.tb00820.x. [DOI] [PubMed] [Google Scholar]
  11. Guerrero R., Velasco F., Rodriguez M., Lopez A., Rojas R., Alvarez M. A., Villalba R., Rubio V., Torres A., del Castillo D. Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor. J Clin Invest. 1993 Jun;91(6):2754–2760. doi: 10.1172/JCI116516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnson K. J., Ward P. A. Protective function of C6 in rabbits treated with bacterial endotoxin. J Immunol. 1971 Apr;106(4):1125–1127. [PubMed] [Google Scholar]
  13. Johnson K. J., Ward P. A. The requirement for serum complement in the detoxification of bacterial endotoxin. J Immunol. 1972 Mar;108(3):611–616. [PubMed] [Google Scholar]
  14. José P. J., Forrest M. J., Williams T. J. Human C5a des Arg increases vascular permeability. J Immunol. 1981 Dec;127(6):2376–2380. [PubMed] [Google Scholar]
  15. Kane M. A., May J. E., Frank M. M. Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation. J Clin Invest. 1973 Feb;52(2):370–376. doi: 10.1172/JCI107193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lowry S. F. Anticytokine therapies in sepsis. New Horiz. 1993 Feb;1(1):120–126. [PubMed] [Google Scholar]
  17. Marcus R. L., Shin H. S., Mayer M. M. An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1351–1354. doi: 10.1073/pnas.68.6.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. May J. E., Kane M. A., Frank M. M. Host defense against bacterial endotoxemia-contribution of the early and late components of complement to detoxification. J Immunol. 1972 Oct;109(4):893–895. [PubMed] [Google Scholar]
  19. Morrison D. C., Kline L. F. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol. 1977 Jan;118(1):362–368. [PubMed] [Google Scholar]
  20. Natanson C., Danner R. L., Elin R. J., Hosseini J. M., Peart K. W., Banks S. M., MacVittie T. J., Walker R. I., Parrillo J. E. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest. 1989 Jan;83(1):243–251. doi: 10.1172/JCI113866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Natanson C., Fink M. P., Ballantyne H. K., MacVittie T. J., Conklin J. J., Parrillo J. E. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest. 1986 Jul;78(1):259–270. doi: 10.1172/JCI112559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Okusawa S., Dinarello C. A., Yancey K. B., Endres S., Lawley T. J., Frank M. M., Burke J. F., Gelfand J. A. C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. J Immunol. 1987 Oct 15;139(8):2635–2640. [PubMed] [Google Scholar]
  23. Okusawa S., Yancey K. B., van der Meer J. W., Endres S., Lonnemann G., Hefter K., Frank M. M., Burke J. F., Dinarello C. A., Gelfand J. A. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med. 1988 Jul 1;168(1):443–448. doi: 10.1084/jem.168.1.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Parrillo J. E., Parker M. M., Natanson C., Suffredini A. F., Danner R. L., Cunnion R. E., Ognibene F. P. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990 Aug 1;113(3):227–242. doi: 10.7326/0003-4819-113-3-227. [DOI] [PubMed] [Google Scholar]
  25. Sacks T., Moldow C. F., Craddock P. R., Bowers T. K., Jacob H. S. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest. 1978 May;61(5):1161–1167. doi: 10.1172/JCI109031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shin H. S., Pickering R. J., Mayer M. M. The fifth component of the guinea pig complement system. II. Mechanism of SAC1,4,2,3,5b formation and C5 consumption by EAC1,4,2,3. J Immunol. 1971 Feb;106(2):473–479. [PubMed] [Google Scholar]
  27. Smedegård G., Cui L. X., Hugli T. E. Endotoxin-induced shock in the rat. A role for C5a. Am J Pathol. 1989 Sep;135(3):489–497. [PMC free article] [PubMed] [Google Scholar]
  28. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  29. Snyderman R., Pike M. C. Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption. Infect Immun. 1975 Feb;11(2):273–279. doi: 10.1128/iai.11.2.273-279.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sprung C. L., Schultz D. R., Marcial E., Caralis P. V., Gelbard M. A., Arnold P. I., Long W. M. Complement activation in septic shock patients. Crit Care Med. 1986 Jun;14(6):525–528. doi: 10.1097/00003246-198606000-00001. [DOI] [PubMed] [Google Scholar]
  31. Stevens J. H., O'Hanley P., Shapiro J. M., Mihm F. G., Satoh P. S., Collins J. A., Raffin T. A. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest. 1986 Jun;77(6):1812–1816. doi: 10.1172/JCI112506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tonnesen M. G., Smedly L. A., Henson P. M. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro. J Clin Invest. 1984 Nov;74(5):1581–1592. doi: 10.1172/JCI111574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ulevitch R. J., Cochrane C. G., Bangs K., Herman C. M., Fletcher J. R., Rice C. L. The effect of complement depletion on bacterial lipopolysaccharide (LPS)-induced hemodynamic and hematologic changes in the Rhesus monkey. Am J Pathol. 1978 Jul;92(1):227–240. [PMC free article] [PubMed] [Google Scholar]
  34. Ulevitch R. J., Cochrane C. G., Henson P. M., Morrison D. C., Doe W. F. Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. J Exp Med. 1975 Dec 1;142(6):1570–1590. doi: 10.1084/jem.142.6.1570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ulevitch R. J., Cochrane C. G. Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changes. Infect Immun. 1978 Jan;19(1):204–211. doi: 10.1128/iai.19.1.204-211.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Winkelstein J. A., Cork L. C., Griffin D. E., Griffin J. W., Adams R. J., Price D. L. Genetically determined deficiency of the third component of complement in the dog. Science. 1981 Jun 5;212(4499):1169–1170. doi: 10.1126/science.7233211. [DOI] [PubMed] [Google Scholar]
  37. Winkelstein J. A., Johnson J. P., Swift A. J., Ferry F., Yolken R., Cork L. C. Genetically determined deficiency of the third component of complement in the dog: in vitro studies on the complement system and complement-mediated serum activities. J Immunol. 1982 Dec;129(6):2598–2602. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES